IL115843A0 - Pharmaceutical composition containing cisapride-(l)-tartrate - Google Patents
Pharmaceutical composition containing cisapride-(l)-tartrateInfo
- Publication number
- IL115843A0 IL115843A0 IL11584395A IL11584395A IL115843A0 IL 115843 A0 IL115843 A0 IL 115843A0 IL 11584395 A IL11584395 A IL 11584395A IL 11584395 A IL11584395 A IL 11584395A IL 115843 A0 IL115843 A0 IL 115843A0
- Authority
- IL
- Israel
- Prior art keywords
- tartrate
- pharmaceutical composition
- composition containing
- containing cisapride
- cisapride
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940095064 tartrate Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cereal-Derived Products (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94203184 | 1994-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL115843A0 true IL115843A0 (en) | 1996-01-31 |
Family
ID=8217338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11584395A IL115843A0 (en) | 1994-11-02 | 1995-11-01 | Pharmaceutical composition containing cisapride-(l)-tartrate |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US6153623A (fr) |
| EP (1) | EP0789572A1 (fr) |
| JP (1) | JP3182423B2 (fr) |
| KR (1) | KR100255521B1 (fr) |
| AP (1) | AP658A (fr) |
| AR (1) | AR001765A1 (fr) |
| AU (1) | AU704284B2 (fr) |
| BG (1) | BG63244B1 (fr) |
| BR (1) | BR9509565A (fr) |
| CA (1) | CA2203663C (fr) |
| CZ (1) | CZ287844B6 (fr) |
| EE (1) | EE03510B1 (fr) |
| FI (1) | FI971856A0 (fr) |
| HR (1) | HRP950539A2 (fr) |
| HU (1) | HUT77887A (fr) |
| IL (1) | IL115843A0 (fr) |
| MY (1) | MY113092A (fr) |
| NO (1) | NO312538B1 (fr) |
| NZ (1) | NZ295166A (fr) |
| OA (1) | OA10419A (fr) |
| PL (1) | PL181470B1 (fr) |
| RO (1) | RO116042B1 (fr) |
| RU (1) | RU2143890C1 (fr) |
| SK (1) | SK54297A3 (fr) |
| TR (1) | TR199501351A2 (fr) |
| TW (1) | TW466114B (fr) |
| UA (1) | UA50721C2 (fr) |
| WO (1) | WO1996014070A1 (fr) |
| ZA (1) | ZA959221B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA959221B (en) * | 1994-11-02 | 1997-04-30 | Janssen Pharmaceutica Nv | Cisapride extended release |
| KR19990067264A (ko) * | 1995-12-01 | 1999-08-16 | 디르크 반테 | 서방형 시사프라이드 |
| DE69713948D1 (de) * | 1996-04-23 | 2002-08-22 | Janssen Pharmaceutica Nv | Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid |
| AU7888298A (en) * | 1997-01-03 | 1998-07-31 | Elan Corporation, Plc | Sustained release cisapride minitablet formulation |
| AU7919398A (en) * | 1997-06-11 | 1998-12-30 | Janssen Pharmaceutica N.V. | Immediate release ph-independent solid dosage form of (+)- or (-)-cisapride |
| TW407058B (en) | 1998-07-17 | 2000-10-01 | Dev Center Biotechnology | Oral cisapride dosage forms with an extended duration |
| JP4928668B2 (ja) | 1999-03-31 | 2012-05-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 制御放出製剤中の前糊化澱粉 |
| EP1060743A1 (fr) * | 1999-06-17 | 2000-12-20 | Development Center For Biotechnology | Formes de dosage de cisapride par voie orale à durée prolongée |
| RU2285519C2 (ru) * | 2000-09-29 | 2006-10-20 | Солвей Фармасьютикалс Б.В. | Фармацевтическая композиция с пролонгированным высвобождением, независимым от ионной силы |
| DE60228939D1 (de) * | 2002-05-21 | 2008-10-30 | Watson Lab Inc | Pharmazeutische Zusammensetzung mit verzögerter Freisetzung |
| US8617596B2 (en) | 2006-04-12 | 2013-12-31 | Nippon Soda Co., Ltd. | Sustained-release tablet production process |
| RU2356532C2 (ru) * | 2007-06-01 | 2009-05-27 | Открытое Акционерное Общество "Отечественные Лекарства" | Фармацевтическая композиция проксодолола с контролируемым высвобождением |
| WO2010099508A1 (fr) | 2009-02-26 | 2010-09-02 | Theraquest Biosciences, Inc. | Compositions pharmaceutiques orales à libération prolongée de 3-hydroxy-n-méthylmorphinane et procédé d'utilisation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1183847A (fr) * | 1981-10-01 | 1985-03-12 | Georges Van Daele | N-(3-hydroxy-4-piperidinyl)benzamide; derives |
| US5057525A (en) * | 1981-10-01 | 1991-10-15 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives |
| WO1993018755A1 (fr) * | 1992-03-25 | 1993-09-30 | Depomed Systems, Incorporated | Formes galeniques de medicament oral a liberation prolongee a base de cellulose a substitution alkyle |
| WO1994001112A1 (fr) * | 1992-07-07 | 1994-01-20 | Sepracor Inc. | Procedes d'utilisation de cisapride (-) pour le traitement du reflux gastro-×sophagien et d'autres troubles |
| ZA959221B (en) * | 1994-11-02 | 1997-04-30 | Janssen Pharmaceutica Nv | Cisapride extended release |
-
1995
- 1995-10-13 ZA ZA959221A patent/ZA959221B/xx unknown
- 1995-10-24 TW TW084111217A patent/TW466114B/zh not_active IP Right Cessation
- 1995-10-25 NZ NZ295166A patent/NZ295166A/xx unknown
- 1995-10-25 JP JP51501196A patent/JP3182423B2/ja not_active Expired - Fee Related
- 1995-10-25 UA UA97052122A patent/UA50721C2/uk unknown
- 1995-10-25 KR KR1019970702799A patent/KR100255521B1/ko not_active IP Right Cessation
- 1995-10-25 BR BR9509565A patent/BR9509565A/pt not_active Application Discontinuation
- 1995-10-25 EE EE9700105A patent/EE03510B1/xx not_active IP Right Cessation
- 1995-10-25 PL PL95319948A patent/PL181470B1/pl not_active IP Right Cessation
- 1995-10-25 EP EP95936551A patent/EP0789572A1/fr not_active Withdrawn
- 1995-10-25 RO RO97-00825A patent/RO116042B1/ro unknown
- 1995-10-25 RU RU97108687/14A patent/RU2143890C1/ru not_active IP Right Cessation
- 1995-10-25 CA CA002203663A patent/CA2203663C/fr not_active Expired - Fee Related
- 1995-10-25 WO PCT/EP1995/004198 patent/WO1996014070A1/fr not_active Application Discontinuation
- 1995-10-25 HU HU9702100A patent/HUT77887A/hu unknown
- 1995-10-25 CZ CZ19971244A patent/CZ287844B6/cs not_active IP Right Cessation
- 1995-10-25 US US08/817,739 patent/US6153623A/en not_active Expired - Fee Related
- 1995-10-25 AU AU38447/95A patent/AU704284B2/en not_active Ceased
- 1995-10-25 SK SK542-97A patent/SK54297A3/sk unknown
- 1995-10-25 AP APAP/P/1997/000969A patent/AP658A/en active
- 1995-10-31 HR HR94.203.184.0A patent/HRP950539A2/hr not_active Application Discontinuation
- 1995-11-01 AR AR33407595A patent/AR001765A1/es not_active Application Discontinuation
- 1995-11-01 IL IL11584395A patent/IL115843A0/xx unknown
- 1995-11-02 TR TR95/01351A patent/TR199501351A2/xx unknown
- 1995-11-02 MY MYPI95003313A patent/MY113092A/en unknown
-
1997
- 1997-04-10 BG BG101401A patent/BG63244B1/bg unknown
- 1997-04-21 NO NO19971832A patent/NO312538B1/no not_active IP Right Cessation
- 1997-04-30 FI FI971856A patent/FI971856A0/fi not_active IP Right Cessation
- 1997-05-02 OA OA70001A patent/OA10419A/en unknown
-
1999
- 1999-10-18 US US09/419,590 patent/US6274599B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9802999A3 (en) | Pharmaceutical composition containing n-propargyl-1-aminoindan | |
| HUP9602056A3 (en) | Novel pharmaceutical composition containing phenofibrate | |
| GB9417524D0 (en) | Pharmaceutical compositions | |
| EP0803255A4 (fr) | Composition medicinale | |
| IL113329A0 (en) | Benzamide-containing pharmaceutical compositions | |
| GB9418609D0 (en) | Pharmaceutical compositions | |
| IL115843A0 (en) | Pharmaceutical composition containing cisapride-(l)-tartrate | |
| HK1021728A1 (en) | Pharmaceutical composition containing 4-oxo-butynic acids | |
| ZA954469B (en) | Pharmaceutical compositions | |
| HU9503031D0 (en) | Pharmaceutical composition containing von willerbrand factor | |
| GB9406835D0 (en) | Pharmaceutical compositions | |
| GB2295825B (en) | Pharmaceutical compositions | |
| HU9601821D0 (en) | Pharmaceutical compositions | |
| HU9400096D0 (en) | Pharmaceutical compositions | |
| GB2285923B (en) | Pharmaceutical compositions containing N-acetal-cysteine | |
| IL115853A (en) | Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas and pharmaceutical compositions containing these compounds | |
| GB2308545A (en) | Pharmaceutical compositions | |
| GB9414183D0 (en) | Pharmaceutical composition | |
| GB9424470D0 (en) | Pharmaceutical composition | |
| GB9405025D0 (en) | Pharmaceutical composition | |
| GB9405024D0 (en) | Pharmaceutical composition | |
| ZA953965B (en) | Pharmaceutical composition | |
| GB9421239D0 (en) | Pharmaceutical composition | |
| GB9420991D0 (en) | Pharmaceutical composition | |
| GB9414182D0 (en) | Pharmaceutical composition |